Concepedia

Leila Dardaei

LD

Statistics

Publications

16

Citations

3.2K

H-Index

15

Active since

2010

Affiliations

Massachusetts General Hospital(Current)

IFOM

Tehran University of Medical Sciences

Harvard University

Shariati Hospital

Leila Dardaei is an author at Massachusetts General Hospital specializing in medicine, oncology, and lung cancer.

Top concepts

Publications per year

2010–2018

16

Publications

16

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer

Justin F. Gainor, Leila Dardaei, Satoshi Yoda et al. · Cancer Discovery · 2016 · 1.1K citations · Full text

Resensitization to Crizotinib by the Lorlatinib<i>ALK</i>Resistance Mutation L1198F

Alice T. Shaw, Luc Friboulet, Ignaty Leshchiner et al. · New England Journal of Medicine · 2015 · 479 citations · Full text

, , +15

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer

Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 298 citations · Full text

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non–Small-Cell Lung Cancer

Justin F. Gainor, Diane Tseng, Satoshi Yoda et al. · JCO Precision Oncology · 2017 · 255 citations

Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

David P. Kodack, Anna F. Farago, Anahita Dastur et al. · Cell Reports · 2017 · 201 citations · Full text

, , +17

1–5 of 16